Document Detail

MedLine Citation:
PMID:  20205488     Owner:  NLM     Status:  MEDLINE    
Fospropofol (fospropofol disodium), a sedative/hypnotic agent, is a water-soluble prodrug of propofol, metabolized in vivo to produce liberated propofol (producing the sedative effect), phosphate and formaldehyde. Intravenous fospropofol 6.5 mg/kg was significantly more effective than fospropofol 2.0 mg/kg (a placebo surrogate) as sedation in patients undergoing colonoscopy or flexible bronchoscopy, with regard to the primary endpoint of sedation success rate in randomized, double-blind, phase III trials. In patients undergoing colonoscopy, the sedation success rate was >3-fold higher among fospropofol 6.5 mg/kg (n = 158) than fospropofol 2.0 mg/kg recipients (n = 102). Similar results were observed in patients undergoing flexible bronchoscopy; the sedation success rate was >3-fold greater among fospropofol 6.5 mg/kg (n = 150) than among fospropofol 2.0 mg/kg recipients (n = 102). Fospropofol was generally well tolerated in clinical trials. Adverse events were mostly of mild to moderate severity, and were transient and self-limiting. Patients undergoing flexible bronchoscopy appeared to have a higher rate of sedation-related adverse events requiring airway assistance than did those undergoing colonoscopy or minor procedures.
Karly P Garnock-Jones; Lesley J Scott
Related Documents :
12453928 - Effects of intramuscular administration of lidocaine or bupivacaine on induction and ma...
7747848 - Effects of propofol and intralipid on immune response and prostaglandin e2 production.
10743448 - Postoperative pain management and recovery after remifentanil-based anaesthesia with is...
3992028 - Effects of ketamine on the catecholamine containing cells of the adrenal gland of the l...
814028 - Abnormal hepatic transport of indocyanine green in gilbert's syndrome.
7004338 - Comparative activities of cefotiam and cefazolin against urinary tract infections with ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drugs     Volume:  70     ISSN:  0012-6667     ISO Abbreviation:  Drugs     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-08     Completed Date:  2010-07-19     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  7600076     Medline TA:  Drugs     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  469-77     Citation Subset:  IM    
Adis, Auckland, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anesthetics, Intravenous / administration & dosage,  adverse effects,  pharmacology,  therapeutic use
Propofol / administration & dosage,  adverse effects,  analogs & derivatives*,  pharmacology,  therapeutic use
Reg. No./Substance:
0/Anesthetics, Intravenous; 2078-54-8/Propofol; LZ257RZP7K/fospropofol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pilsicainide.
Next Document:  Tadalafil: in pulmonary arterial hypertension.